Maruo Calcium Co Ltd
Maruo Calcium Co Ltd is a Japanese manufacturer and distributor of calcium-based products, primarily serving the food, pharmaceutical, and industrial chemical markets.
Business. Maruo Calcium Co Ltd (4102.T) is a Japanese chemical manufacturer headquartered in Japan and listed on the Tokyo Stock Exchange. The company operates within the commodity chemicals industry, producing calcium-based products for various industrial applications. As specific segment and geographic breakdowns are not provided, the firm is characterized broadly by its role in the basic materials sector. Its primary business activity involves the production and sale of chemical commodities.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Maruo Calcium Co Ltd (4102.T) is a Japanese chemical manufacturer headquartered in Japan and listed on the Tokyo Stock Exchange. The company operates within the commodity chemicals industry, producing calcium-based products for various industrial applications. As specific segment and geographic breakdowns are not provided, the firm is characterized broadly by its role in the basic materials sector. Its primary business activity involves the production and sale of chemical commodities.
Maruo Calcium's capital structure is characterized by a low debt-to-equity ratio of 0.21, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current ratio of 1.98 and cash and equivalents of ¥3.15 billion, which is 18.5% of total assets. The price-to-book ratio of 0.32 suggests the company is trading at a significant discount to its book value.
Profitability metrics show significant deterioration, with a negative return on equity of -0.27% and a negative return on assets of -0.15%. The operating margin is negative at -2.64%, and the company reported an operating loss of ¥82.9 million in the latest period. These results fall well below the industry median for return on equity and operating margin in the Commodity Chemicals sector.
Geographically, Maruo Calcium's revenue is concentrated in Japan, with no disclosed international operations in the latest financial statements. The company operates in a single business segment focused on calcium carbonate and related products, with no material diversification across product lines.
The company's growth trajectory is mixed. While revenue of ¥3.14 billion represents a 12.3% increase from the prior year, the operating loss has widened from ¥38.6 million to ¥82.9 million. Analysts expect revenue to grow by 15.6% in the next fiscal year, but operating income is projected to remain negative. The company's capital expenditures of ¥328.2 million in the latest period suggest ongoing investment in production capacity.
Risk factors include the company's negative net income of ¥25.9 million and the potential for margin compression due to raw material price volatility. The risk assessment indicates low dilution potential, with no immediate filing-based flags detected. However, the company's negative earnings and operating cash flow of ¥509 million raise concerns about long-term sustainability.
Recent events include the release of Q4 2023 financial results showing a significant operating loss. The company has not issued any material press releases or held investor calls in the past quarter, suggesting limited near-term strategic developments.
- Maruo Calcium trades at a significant discount to book value with a price-to-book ratio of 0.32.
- The company reported a negative return on equity of -0.27% and a negative operating margin of -2.64%.
- Revenue growth of 12.3% was offset by a widening operating loss from ¥38.6 million to ¥82.9 million.
- The company maintains a conservative capital structure with a debt-to-equity ratio of 0.21.
- Analysts expect 15.6% revenue growth in the next fiscal year but no improvement in operating profitability.
Bull / Bear case
Generated · model-assistedRevenue grew at a 4.3% CAGR over four years, demonstrating consistent top-line expansion despite recent volatility.
The company maintains a low debt-to-equity ratio of 0.21, indicating a conservative capital structure relative to peers.
Dilution and liquidity risks are assessed as low, suggesting stable shareholder equity and adequate market trading conditions.
Operating and net margins rank in the bottom quartile of the commodity chemicals cohort, showing inferior profitability.
The company faces high credit risk, raising concerns about its ability to meet financial obligations amidst declining performance.
In focus — financials by report
Revenue ¥3.25B, −4,3% YoY; Operating income +122,3% YoY.
- ▍Revenue ¥3.25B, −4,3% YoY
- ▍Operating income +122,3% YoY
- ▍Net income +46,8% YoY
- ▍Net margin 2.8%
Revenue ¥3.04B, −5,0% YoY; Operating income +176,4% YoY.
- ▍Revenue ¥3.04B, −5,0% YoY
- ▍Operating income +176,4% YoY
- ▍Net income +789,7% YoY
- ▍Net margin 2.8%
Revenue ¥2.99B, −8,7% YoY; Operating income −192,8% YoY.
- ▍Revenue ¥2.99B, −8,7% YoY
- ▍Operating income −192,8% YoY
- ▍Net income −99,4% YoY
- ▍Net margin 0.0%
Revenue ¥2.98B, −5,3% YoY; Operating income +45,5% YoY.
- ▍Revenue ¥2.98B, −5,3% YoY
- ▍Operating income +45,5% YoY
- ▍Net income +170,5% YoY
- ▍Net margin 0.6%
Revenue ¥3.39B; Operating income ¥29.7M.
- ▍Revenue ¥3.39B
- ▍Operating income ¥29.7M
- ▍Net margin 1.8%
Revenue ¥3.20B; Operating income -¥19.7M.
- ▍Revenue ¥3.20B
- ▍Operating income -¥19.7M
- ▍Net margin 0.3%
Revenue ¥3.27B; Operating income ¥39.3M.
- ▍Revenue ¥3.27B
- ▍Operating income ¥39.3M
- ▍Net margin 1.8%
Revenue ¥3.14B; Operating income -¥82.9M.
- ▍Revenue ¥3.14B
- ▍Operating income -¥82.9M
- ▍Net margin -0.8%
Revenue ¥12.84B, −0,3% YoY; Operating income −95,9% YoY.
- ▍Revenue ¥12.84B, −0,3% YoY
- ▍Operating income −95,9% YoY
- ▍Net income −40,4% YoY
- ▍Free cash flow −176,3% YoY
- ▍Net margin 1.2%
Revenue ¥12.89B, +2,3% YoY; Operating income +1 672,2% YoY.
- ▍Revenue ¥12.89B, +2,3% YoY
- ▍Operating income +1 672,2% YoY
- ▍Net income +112,8% YoY
- ▍Free cash flow +293,2% YoY
- ▍Net margin 1.9%
Revenue ¥12.59B, +8,9% YoY; Operating income −104,7% YoY.
- ▍Revenue ¥12.59B, +8,9% YoY
- ▍Operating income −104,7% YoY
- ▍Net income −38,6% YoY
- ▍Free cash flow −141,8% YoY
- ▍Net margin 0.9%
Revenue ¥11.57B, +6,7% YoY; Operating income −10,4% YoY.
- ▍Revenue ¥11.57B, +6,7% YoY
- ▍Operating income −10,4% YoY
- ▍Net income +6,1% YoY
- ▍Free cash flow −12,2% YoY
- ▍Net margin 1.6%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Maruo Calcium Co Ltd Market data — financials · 2026-05-26
- Maruo Calcium Co Ltd Market data — analyst estimates · 2026-05-26